Effect of valproic acid usage on serum protein and immuneglobulin levels in epileptic patients

Basit Öğe Kaydı
dc.authoridSangun, Ozlem/0000-0002-9079-4574
dc.authoridDUMAN, Taskin/0000-0002-6552-4193
dc.contributor.authorIncecik, Faruk
dc.contributor.authorSangun, Oziem
dc.contributor.authorMelek, Ismet
dc.contributor.authorDuman, Taskin
dc.date.accessioned2024-09-18T20:08:17Z
dc.date.available2024-09-18T20:08:17Z
dc.date.issued2007
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractPurpose: The aim of this study was to research the possible effect of VPA usage on serum protein and immunoglobulin (Ig) levels in epileptic patients. Material and methods: Twenty-five patients followed up after being diagnosed with epilepsy for a minimum of 6 months and were treated with VPA formed the experimental group. In all cases, serum protein and Ig levels, as well as VPA levels were measured. It has been investigated that in VPA using group whether serum protein and Ig levels affected VPA usage doses, treatment period, and levels in addition to the age and sex distribution. Results: There was no statistically significant difference in total protein, albumin, and Ig levels between VPA treatment and control groups. It was determined that in the epileptic group serum protein, albumin, Ig A, M, and G levels were not affected by the VPA serum levels, dosage or treatment duration or age and gender. Conclusion: While the treatment of VPA on epileptic patients, which requires long term usage, a regular follow up for serum proteins and immunoglobulins should be done and because of different results in different studies we suggest that more extensive studies should be performed for the definite results.en_US
dc.identifier.endpage214en_US
dc.identifier.issn2149-2247
dc.identifier.issn2149-2549
dc.identifier.issue3en_US
dc.identifier.scopus2-s2.0-34548637312en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage210en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12483/8751
dc.identifier.volume29en_US
dc.identifier.wosWOS:000421144500006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.publisherAvesen_US
dc.relation.ispartofErciyes Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectChildrenen_US
dc.subjectEpilepsyen_US
dc.subjectImmunisglisbilinsen_US
dc.subjectSerum albuminen_US
dc.subjectValpridic adden_US
dc.titleEffect of valproic acid usage on serum protein and immuneglobulin levels in epileptic patientsen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ N/A ]
İsim:
Tam Metin / Full Text
Boyut:
65.83 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu